Emis Group (EMIS) Downgraded to Add at Numis Securities

Share on StockTwits

Numis Securities cut shares of Emis Group (LON:EMIS) to an add rating in a research report sent to investors on Thursday. Numis Securities currently has GBX 1,160 ($14.96) price target on the stock, up from their prior price target of GBX 880 ($11.35).

Shares of EMIS traded down GBX 1 ($0.01) during trading hours on Thursday, reaching GBX 974 ($12.56). The stock had a trading volume of 61,120 shares, compared to its average volume of 171,465. Emis Group has a 12 month low of GBX 9.42 ($0.12) and a 12 month high of GBX 1,034 ($13.34).

The company also recently announced a dividend, which will be paid on Friday, November 2nd. Investors of record on Thursday, September 27th will be issued a GBX 14.20 ($0.18) dividend. This is a boost from Emis Group’s previous dividend of $12.90. This represents a dividend yield of 1.47%. The ex-dividend date of this dividend is Thursday, September 27th.

In other news, insider Andrew McKeon bought 2,000 shares of the business’s stock in a transaction that occurred on Thursday, June 28th. The shares were bought at an average cost of GBX 889 ($11.47) per share, for a total transaction of £17,780 ($22,936.02). Over the last quarter, insiders purchased 2,050 shares of company stock worth $1,823,576.

About Emis Group

EMIS Group plc, through its subsidiaries, provides healthcare software, information technology, and related services for healthcare professionals in the United Kingdom. It operates in four segments: Primary, Community & Acute Care; Community Pharmacy; Specialist & Care; and Patient. The company offers clinical management systems that hold patient records for healthcare providers and commissioners; dispensary pharmacy management software for the community pharmacy market; and Egton non-clinical software for health and social care.

See Also: Average Daily Trade Volume – What It Means In Stock Trading

Receive News & Ratings for Emis Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Emis Group and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply